Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer

Computational Drug Repositioning: From Data to Therapeutics

(2013) M R Hurle et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

New sources of drugs for hematologic malignancies

(2011) M. A. Sukhai et al.   BLOOD

Nocodazole is a High-Affinity Ligand for the Cancer-Related Kinases ABL, c-KIT, BRAF, and MEK

(2011) Hwangseo Park et al.   ChemMedChem

Comprehensive analysis of kinase inhibitor selectivity

(2011) Mindy I Davis et al.   NATURE BIOTECHNOLOGY

How were new medicines discovered?

(2011) David C. Swinney et al.   NATURE REVIEWS DRUG DISCOVERY

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

(2011) Ren-Yuan Bai et al.   NEURO-ONCOLOGY

PROMISCUOUS: a database for network-based drug-repositioning

(2010) J. von Eichborn et al.   NUCLEIC ACIDS RESEARCH

Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer

(2009) Mohammad H. Pourgholami et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Novel trends in high-throughput screening

(2009) Lorenz M Mayr et al.   CURRENT OPINION IN PHARMACOLOGY

The fluorometric microculture cytotoxicity assay

(2008) Elin Lindhagen et al.   Nature Protocols